← All institutions

Nomura

110 reports

Reports from this institution

Nomura

Nomura: Hubei Dinglong: Semiconductor materials account for a larger share as third-quarter revenue edges up and net profit rises 55%

Growth in semiconductor materials and the disposal of some printing consumables businesses changed the revenue mix, helping lift the third-quarter gross margin year over year. Nomura is optimistic about CMP polishing pad capacity expansion and growing photoresist sales, but display materials remain under near-term pressure from panel makers’ utilization rates.

Nomura

Nomura: Tianfu Communication’s third-quarter growth rebounds: passive components improve margins, while optical engines remain constrained by component shortages

Nomura raised its earnings forecasts for Tianfu Communication for 2027–2028, citing strong prospects for high-margin passive components and demand for NPO and CPO. However, optical-engine component shortages lowered its 2026 expectations, while a reduced valuation multiple also brought its target price down to 232 yuan.

Nomura

Nomura: Hengrui Pharma's drug sales return to growth in the third quarter as collaboration revenue boosts profit

Nomura estimates that Hengrui's third-quarter drug sales grew 4.9% year on year, reversing the previous quarter's decline. A sharp increase in collaboration revenue pushed total revenue and net profit attributable to shareholders above Bloomberg consensus estimates, although full-year growth in innovative drug sales may fall short of the company's target set at the start of the year.